glp 1 hormone therapy Can support better weight loss outcomes with GLP-1 medications? Emerging research suggests it might. A 2024 study found that postmenopausal women who used hormone replacement therapy (HRT) alongside a GLP-1 The GLP-1/GIP dual-receptor agonist tirzepatide

It works by slowing gastric emptying and enhancing satiety signals, which leads to reduced calorie intake

L-carnitine plays an important role in maintaining metabolic flexibility in the human body

Dosage, Concentration and Route of Administration Dosage: 1 capsule daily Concentration (per mL): Not applicable (PeptideVite is provided in capsule form) Volume: 60 capsules per bottle Route of Administration: Oral For more detailed instructions and information, please consult your healthcare provider or refer to the product packaging

Whilst Saxenda is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for obesity treatment, changes in libido are not listed as recognised side effects in the UK Summary of Product Characteristics

Your clinician will weigh risks and benefits and may suggest a different plan if GLP-1s arent a fit